Skip to content
Search

Latest Stories

Pharmacists can deliver more, but need better support, MSPs told

The Royal Pharmaceutical Society (RPS) Scotland has highlighted the ability of pharmacists to deliver more in primary care, but urged the Scottish Parliament to provide proper workforce planning for pharmacy teams similar to doctors and nurses.

Providing evidence to the parliament's Health, Social Care and Sport Committee as part of their alternative pathways into primary care inquiry, Clare Morrison, director for Scotland at RPS, noted that pharmacy already provides various alternative pathways into primary care through community pharmacy services, pharmacists working in GP practices, and specialist pharmacy services in community settings.


"There needs to be proper workforce planning for pharmacy teams, in the same way there is for doctors and nurses," for the pharmacists to provide better services, Morrison said.

"This should include investment in more pharmacy technicians and pharmacy support workers who will release pharmacists’ capacity to expand their roles into areas such as: advising on medicines, acting as a first port of call for common clinical conditions and ensuring medicines are safe and effective."

She also stressed the need to expand the training places for independent prescribing, so that by 2030 most pharmacists can prescribe, which will improve quality and accessibility of care for patients.

"There should be investment in digital technologies such as electronic prescribing and a single shared patient record to improve patient experience, quality, and safety," Morrison added.

During the evidence session, Morrison highlighted a recent Ipsos MORI survey of 1,107 adults in Scotland showing very clear public support for the professional roles of pharmacists:

  • 95% of people support pharmacists advising on medicines.
  • 87% of people think it is important that pharmacists prescribe medicines.
  • 89% of people think pharmacists should be the first port of call for common clinical conditions.
  • 81% think pharmacists should be monitoring, reviewing and adjusting medicine for long term conditions.

Morrison commented: “Pharmacy teams have the potential to be delivering even more, but to do this, it is vital that there is investment in areas such as independent prescribing, getting the right skill mix across pharmacy teams and introduction of new digital technologies like electronic prescribing and a shared patient record.”

More For You

Trump signs executive order to accelerate US-based pharmaceutical manufacturing plants

US president Donald Trump

Pic credit: Getty Images

Trump signs executive order to encourage US drug manufacturing

US president Donald Trump signed an executive order on Monday that aims to reduce the time it takes to approve pharmaceutical plants in the country, as part of new regulations to encourage domestic manufacturing.

The order directs the US Food and Drug Administration to streamline reviews and work with domestic manufacturers to provide early support before facilities come online.

Keep ReadingShow less
Community Pharmacy Scotland secures £10m reimbursement uplift amid ongoing negotiations

Negotiations continue on the Global Sum element of remuneration.

Getty Images

Community Pharmacy Scotland secures £120m reimbursement deal for 2025/26

Community Pharmacy Scotland (CPS) has accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

The agreement marks the first phase of ongoing negotiations surrounding community pharmacy funding for the upcoming financial year.

Keep ReadingShow less
NICE approves once-daily tablet Linzagolix for endometriosis

NICE recommends Linzagolix with add-back therapy for endometriosis

Image credit: Getty Images

NICE approves new at-home treatment for endometriosis

The National Institute for Health and Care Excellence (NICE) has recommended Linzagolix (brand name Yselty), a once-daily tablet, as a new treatment option for endometriosis.

Developed by Theramex, Linzagolix is approved for use alongside hormonal add-back therapy in adults of reproductive age who have previously tried other medical or surgical treatments for the condition.

Keep ReadingShow less
Many patients report inaccuracies or missing details in their NHS medical records

Inaccurate information can result in serious harm or even death, warns Healthwatch England.

Image Credit: Getty Images

1 in 4 adults have spotted errors in their NHS medical records, survey finds

Healthwatch England has raised the alarm over the risks posed by inaccurate medical records as research reveals widespread errors in NHS patient information.

Commissioned by Healthwatch England and conducted by BMG Research, the survey polled a representative sample of 1,800 adults in England between 24 and 27 March 2025.

Keep ReadingShow less